Prof Ian Douglas
Professor of Pharmacoepidemiology
I am an epidemiologist, currently funded by GlaxoSmithKline. I initially studied physiology at BSc and PhD level in Manchester. Since then, I spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutical industry investigating adverse effects of drugs - both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005.
Most of my teaching is split between the LSHTM pharmacoepidemiology range of short courses and the MSc in Epidemiology,
I am interested in pharmacoepidemiology, and in particular, how large electronic health record databases can be used to investigate the effects of drugs - both harmful and beneficial. I am exploring methodologies to minimize some of the biases inherent in the research of drug effects, and my main current areas of interest include case-only approaches to study design, the use of non-interventional data to estimate intended treatment effects, quantitative bias analysis, and the application of high dimensional propensity scores in electronic health data.